Search - tctmd.com

Displaying 141 - 160 of 245

Sort: Relevancy | Date

Presentation THT 2023

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

Presenter: Alexandre Mebazaa

March 20, 2023

Presentation THT 2023

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Presenter: Babar Basir

March 20, 2023

Presentation THT 2023

Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)?

Presenter: Dirk Westermann

March 20, 2023

Presentation THT 2023

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Presenter: Gregg Stone

March 20, 2023

Presentation THT 2023

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Presenter: A. Reshad Garan

March 20, 2023

Presentation THT 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Presenter: Manreet Kanwar

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

Presentation THT 2023

Outcomes of cardiogenic shock in patients with chronic systolic vs diastolic heart failure: A nationwide analysis

Presenter: Dhairya Nanavaty

March 20, 2023

Presentation THT 2023

The use of Invasive Hemodynamic Monitoring in Patients with Cardiogenic Shock has Increased Over Time: Insights in Trends for Early Mortality, Readmission Rates and Mechanical Circulatory Support Use from the National Readmissions Database

Presenter: Abhinav Aggarwal

March 20, 2023

News Daily News

HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline

Shelley Wood

January 04, 2023

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Impella RP Mortality Rate No Longer a Concern, FDA Says

Caitlin E. Cox

December 05, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2022

Caitlin E. Cox

December 01, 2022

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

Caitlin E. Cox

November 06, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Conference News TCT 2022

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

Shelley Wood

September 18, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Conference News ESC 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

L.A. McKeown

August 27, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Shelley Wood

August 11, 2022

Advertisement

SEISMiC Trial: Isatroxime (lusi-inotrope) (HF shock)

SSO2 for AMI Shock: The ISO-Shock Trial (AMI)

Should All ECMO Patients Receive LV Unloading (Include HYPO-ECMO)?

Impella for Cardiogenic Shock: High Expectations From Ongoing Studies

Cardiogenic Shock: Customized Therapeutic Approaches in 2023

Cardiogenic Shock: Patient Phenotyping and Prognostication

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Outcomes of cardiogenic shock in patients with chronic systolic vs diastolic heart failure: A nationwide analysis

The use of Invasive Hemodynamic Monitoring in Patients with Cardiogenic Shock has Increased Over Time: Insights in Trends for Early Mortality, Readmission Rates and Mechanical Circulatory Support Use from the National Readmissions Database

HF Specialists Detail ‘Road Map’ for Improving HF Training Pipeline

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Impella RP Mortality Rate No Longer a Concern, FDA Says

TCTMD’s Top 10 Most Popular Stories for November 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

November 2022 News Roundup

Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Old Drug Acetazolamide Offers New Tricks in Acute HF: ADVOR

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Dobutamine Shortage: ACC Experts Offer Tips, Alternatives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content